Researchers Database

MAGARA Tetsuya

Graduate School of Medical Sciences Department of Geriatric and Environmental Dermatology　Lecturer

Last Updated :2026/08/13

Life‐Threatening Potential of Deep Fistulas in Hidradenitis Suppurativa: A Case of Axillary Vessel‐Adjacent Lesion With MMP Overexpression
Momoko Higuchi; Hiroshi Kato; Maki Yoshimitsu; Tetsuya Magara; Kasumi Kato; Motoki Nakamura; Akimichi Morita
The Journal of Dermatology Wiley 53 (4) 0385-2407 2026/02

Spatial proteomics of tertiary lymphoid structures reveals correlation with immunotherapy response in Merkel cell carcinoma
Motoki Nakamura; Dai Ogata; Junji Kato; Yi-Wen Ko; Jiayue Hu; Maki Yoshimitsu; Tetsuya Magara; Shinji Kano; Reiko Nakamura; Hiroshi Kato; Takeo Maekawa; Masahito Yasuda; Yukiko Kiniwa; Hideyuki Ishikawa; Yasuhiro Nakamura; Kotaro Nagase; Akimichi Morita
British Journal of Dermatology Oxford University Press (OUP) 194 (5) 888 - 898 0007-0963 2025/12

Postoperative Complications and Risk Factors in Skin Tumor Excision With Simple Suturing Under Local Anesthesia: A Multicenter Retrospective Study in Japan
Kasumi Kato; Hiroshi Kato; Tetsuya Magara; Akimichi Morita
The Journal of Dermatology Wiley 52 (12) 1803 - 1810 0385-2407 2025/09

CXCL13 and CCL21 Induce Tertiary Lymphoid Structures and Enhance the Efficacy of Immunotherapy for Melanoma.
Maki Yoshimitsu; Motoki Nakamura; Shinji Kano; Tetsuya Magara; Hiroshi Kato; Aiko Sakai; Masaya Sugiyama; Masashi Mizokami; Akimichi Morita
Cancer science 116 (8) 2075 - 2085 2025/08

Tertiary lymphoid structures associated with improved prognosis and reduced invasion in advanced extramammary Paget disease.
Tetsuya Magara; Motoki Nakamura; Maki Yoshimitsu; Yukiko Yasui; Shinji Kano; Hiroshi Kato; Akimichi Morita
Clinical and experimental dermatology 50 (3) 666 - 668 2025/02

Blockade of glucose-6-phosphate dehydrogenase induces immunogenic cell death and accelerates immunotherapy.
Motoki Nakamura; Tetsuya Magara; Maki Yoshimitsu; Shinji Kano; Hiroshi Kato; Keisuke Yokota; Katsuhiro Okuda; Akimichi Morita
Journal for immunotherapy of cancer 12 (7) 2024/07

Analyses of tertiary lymphoid structures observed in cases of Merkel cell carcinoma showing spontaneous regression.
Motoki Nakamura; Maki Yoshimitsu; Tetsuya Magara; Shinji Kano; Hiroshi Kato; Akimichi Morita
Experimental dermatology 33 (3) e15062 2024/03

Differences in the immune microenvironment between improved and non-improved cases of vitiligo after halo nevus excision.
Shinji Kano; Motoki Nakamura; Yuka Nojiri; Tetsuya Magara; Maki Yoshimitsu; Hiroshi Kato; Akimichi Morita
Journal of dermatological science 109 (3) 136 - 142 2023/03

Influence of aldo-keto reductase 1C3 polymorphisms in early-onset female psoriasis patients.
Yuka Nojiri; Motoki Nakamura; Tetsuya Magara; Aya Yamamoto; Kyoko Ikumi; Reiko Nakamura; Emi Nishida; Thomas Haarmann-Stemmann; Akimichi Morita
Scientific reports 13 (1) 3280 - 3280 2023/02

Tumor immune microenvironment of cutaneous angiosarcoma with cancer testis antigens and the formation of tertiary lymphoid structures.
Tetsuya Magara; Motoki Nakamura; Yuka Nojiri; Maki Yoshimitsu; Shinji Kano; Hiroshi Kato; Akimichi Morita
Frontiers in oncology 13 1106434 - 1106434 2023

Tertiary Lymphoid Structures and Chemokine Landscape in Virus-Positive and Virus-Negative Merkel Cell Carcinoma.
Motoki Nakamura; Tetsuya Magara; Shinji Kano; Akihiro Matsubara; Hiroshi Kato; Akimichi Morita
Frontiers in oncology 12 811586 - 811586 2022

Dynamic changes in tumor immunity in a case of cutaneous angiosarcoma with recurrent lesions.
Tetsuya Magara; Motoki Nakamura; Shinji Kano; Hiroshi Kato; Rieko Oshima; Daisuke Kawakita; Akimichi Morita
The Journal of dermatology 48 (11) e564-e565 2021/11

Tertiary lymphoid structures correlate with better prognosis in cutaneous angiosarcoma.
Tetsuya Magara; Motoki Nakamura; Yuka Nojiri; Maki Yoshimitsu; Shinji Kano; Akihiro Matsubara; Hiroshi Kato; Akimichi Morita
Journal of dermatological science 103 (1) 57 - 59 2021/07

Glucose-6-phosphate dehydrogenase correlates with tumor immune activity and programmed death ligand-1 expression in Merkel cell carcinoma.
Motoki Nakamura; Kotaro Nagase; Maki Yoshimitsu; Tetsuya Magara; Yuka Nojiri; Hiroshi Kato; Tadahiro Kobayashi; Yukiko Teramoto; Masahito Yasuda; Hidefumi Wada; Toshiyuki Ozawa; Yukie Umemori; Dai Ogata; Akimichi Morita
Journal for immunotherapy of cancer 8 (2) 2020/12

Increased programmed death ligand-1 expression in metastatic Merkel cell carcinoma associates with better prognosis.
Motoki Nakamura; Tetsuya Magara; Yuka Nojiri; Haruna Nishihara; Hiroshi Kato; Yukiko Teramoto; Masahito Yasuda; Hidefumi Wada; Toshiyuki Ozawa; Yukie Umemori; Dai Ogata; Tadahiro Kobayashi; Maiko Hata; Kotaro Nagase; Akimichi Morita
Journal of dermatological science 97 (2) 165 - 167 2020/02

Heterogeneity of programmed death‐ligand expression in a case of Merkel cell carcinoma exhibiting complete regression after multiple metastases
M. Nakamura; T. Magara; Y. Kobayashi; H. Kato; S. Watanabe; A. Morita
British Journal of Dermatology Oxford University Press (OUP) 180 (5) 1228 - 1229 0007-0963 2019/01